The serpin α 2 -antiplasmin (SERPINF2) is the principal inhibitor of plasmin and inhibits fibrinolysis. Accordingly, α 2 -antiplasmin deficiency in humans results in uncontrolled fibrinolysis and a bleeding disorder. α 2 -antiplasmin is an unusual serpin, in that it contains extensive N-and C-terminal sequences flanking the serpin domain.
Introduction
Vertebrate vascular integrity is protected by a sophisticated hemostatic mechanism which, when activated by trauma, leads to the formation of a fibrin rich clot. Simultaneously the fibrinolytic system is activated to begin the process of remodelling and removing the clot during tissue repair 1 . Fibrinolysis is initiated by trace quantities of tissue plasminogen activator (tPA) derived from endothelial cells.
In the presence of fibrin, tPA cleaves the protease plasminogen (which comprises an apple domain, five kringle domains [K1-K5] and a C-terminal serine protease domain 2 ) between the fifth kringle domain and the protease domain to form plasmin, which mediates clot lysis 3 . All six domains of plasmin remain associated via a disulphide bond after cleavage 4 . The physiological inhibitor of plasmin (k a 3. ) 5 is α 2 -antiplasmin and patients deficient in this serpin suffer a variable, but often severe, bleeding disorder 6, 7 . By contrast, mice with a targeted deletion of α 2 -antiplasmin have a normal hemostatic response to minor trauma, presumably because the deficient animals plasma contained significant residual plasmin inhibitory activity 8 . However, when challenged with artificially induced pulmonary emboli, the deficient mice have a greater survival rate than the wild type (41.7% mortality vs.
68.8%) consistent with up-regulation of the fibrinolytic system 9 . These data suggest that therapeutic intervention in the plasmin/α 2 -antiplasmin interaction may be of benefit to patients with thrombotic disorders.
α 2 -antiplasmin contains extensive N-and C-terminal sequences that flank the serpin domain (supplementary Figure 1) . The N-terminal sequence is crosslinked to fibrin by factor XIIIa 10 . The 55 amino acid C-terminal sequence binds to the K1 and K4 domains of plasmin most strongly (K2 and K5 with lower affinity) 8, 11 and enhances the rate of interaction between plasmin and α 2 -antiplasmin by 30-60 fold 5 . It is suggested that the C-terminus acts to "template" the interaction with plasmin, bringing its active site into apposition with the serpin reactive site 8 .
To understand the role of α 2 -antiplasmin in regulating fibrinolysis and the function of the C-terminus we report the X-ray crystal structure of an N-terminally truncated recombinant murine α 2 -antiplasmin.
Study design
Murine α The second-order rate constant for plasmin inhibition by α 2 -antiplasmin ∆43
was determined under pseudo-first-order conditions using a continuous assay 13 . α 2 -antiplasmin ∆43 (0.5nM) was reacted with human plasmin (2.5-6nM) in the presence of 1mM S-2251 at 25°C. (Table 1) .
For personal use only. on November 12, 2017. by guest www.bloodjournal.org From These data were processed using MOSFLM 14 and SCALA 14 . Five percent of the dataset was flagged for calculation of the R free with neither a sigma, nor a lowresolution cut-off applied to the data. Crystallographic analyses were performed using CCP4i 14 .
The structure was solved using molecular replacement (using 1YXA 12 as a search probe) and the program PHASER 15 . Refinement was performed using CNS 16 and REFMAC 14 (with TLS) and a bulk solvent correction (Babinet model with mask).
Model building was carried out using COOT. Water molecules were added using ARP/wARP when the R free reached 30%.
Results and discussion
Murine α 2 -antiplasmin ∆43 is an effective inhibitor of human plasmin (k a 4.01 
-antiplasmin ∆43 with the antitrypsin / trypsin Michaelis complex 21 reveals that the α 2 -antiplasmin RCL may be too short to form significant interactions with plasmin outside the active site. In contrast, the P7-P10 region of antitrypsin forms a short α-helix that interacts with a trypsin exosite (Figure 1b) .
The C-terminal portion of the RCL joins onto the first strand (s1C) of the Csheet. In α 2 -antiplasmin, a conservative mutation in s1C of a buried hydrophobic residue (Val384Met) results in a bleeding disorder 7 . Mutations in this region in other serpins result in reduced inhibitory activity through misfolding, disruption of the conformation of the RCL or by promoting serpin polymerisation 22 .
α 2 -antiplasmin is one of two known F-clade serpins 17 . The other member of this clade, SERPINF1, is a non-inhibitory serpin that possesses potent anti-angiogenic activity 23 . The role of α 2 -antiplasmin in angiogenesis remains to be investigated, however, the potential for the C-terminal sequence to interact with integrins 24 may point to a role for this molecule outside haemostasis.
The C-terminal sequence of α 2 -antiplasmin interacts with the kringle domains of plasmin and facilitates formation of the α 2 -antiplasmin/plasmin complex.
Accordingly, a form of α 2 -antiplasmin lacking the extended C-terminus reacts much more slowly with plasmin 25 . Our structural studies reveal that the first 10 amino acids of the C-terminus (410-419) of α 2 -antiplasmin ∆43 are tightly associated with the serpin body (Figure 1a-b) . A sharp kink in the C-terminus mediated by Pro411, permits residues 416-417 to form an additional β-strand (termed s4'C) at the beginning of strand s3C of the C β-sheet (Figure 1c ). The remainder of the C-terminus (residues 420-464), which includes the known plasmin-binding residue Lys464, cannot be modelled into electron density, suggesting that this region is flexible in the absence of plasmin.
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The structures of intact plasminogen or plasmin have not been reported, precluding a detailed modelling study of the α 2 -antiplasmin / plasmin complex.
However, the structure reveals that the interactions between residues 410-419 of the C-terminus and the serpin body position the C-terminal sequence <30Å from the RCL (Figure 1a-b) , where it would be in an appropriate position to bridge to plasmin.
To conclude, our data suggest that the α 2 -antiplasmin RCL is structured for simple substrate-like interaction with the protease, and that the C-terminal region may function as a "hook" that accelerates the interaction with plasmin into the physiological range. Further, the structure may provide a foundation for the design of compounds to disrupt the α 2 -antiplasmin / plasmin interaction in thrombosis. 
Figure 1
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